Shell Asset Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Shell Asset Management’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-10,432	Closed	-$210K	–	1423
2021 Q3	$210K	Sell	10,432 -450	-4%	-$12.4K	﹤0.01%	1189
2021 Q2	$406K	Buy	10,882 +590	+6%	+$18.1K	0.01%	1007
2021 Q1	$263K	Buy	+10,292	New	+$263K	0.01%	1074

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

Shell Asset Management's DRNA Position: Q4 2021 in Review

Shell Asset Management sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 10,432 shares — an estimated $210K sold.

Shell Asset Management first reported a position in DRNA in Q1 2021 and held it in 3 quarters. The position peaked at $406K in Q2 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

Shell Asset Management reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
Shell Asset Management sold 10,432 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $210K.
Shell Asset Management first reported a position in Dicerna Pharmaceuticals, Inc. in Q1 2021 and held it in 3 quarters.
Shell Asset Management's Dicerna Pharmaceuticals, Inc. position peaked at $406K in Q2 2021.
1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on Shell Asset Management's 13F filing for Q4 2021, filed 9 Feb 2022.